{"id":38056,"date":"2009-04-28T15:15:45","date_gmt":"2009-04-28T13:15:45","guid":{"rendered":"https:\/\/mediarun.com\/index.php\/news-posts\/debiut-reklamowy-leku-claritine-spe\/"},"modified":"2009-04-28T15:15:45","modified_gmt":"2009-04-28T13:15:45","slug":"debiut-reklamowy-leku-claritine-spe","status":"publish","type":"post","link":"https:\/\/mediarun.com\/pl\/marketing\/atl\/debiut-reklamowy-leku-claritine-spe.html","title":{"rendered":"Debiut reklamowy leku Claritine SPE"},"content":{"rendered":"<p>Jest to debiut reklamowy produktu na rynku polskim. Komunikacja obejmuje emisj\u0119 spot&oacute;w w stacjach telewizyjnych o zasi\u0119gu og&oacute;lnopolskim oraz w kana\u0142ach niszowych.<\/p>\n<p>Claritine SPE nale\u017cy do grupy lek&oacute;w przeciwhistaminowych ameryka\u0144skiej firmy Schering-Plough; leczy objawy alergicznego nie\u017cytu nosa i pokrzywki idiopatycznej.<\/p>\n<p>Za opracowanie i wdro\u017cenie strategii oraz planowanie i zakup medi&oacute;w wszystkich marek producenta odpowiada dom mediowy The Media Insight. Kreacj\u0119 przygotowa\u0142a agencja Euro RSCG. Dzia\u0142ania potrwaj\u0105 do po\u0142owy czerwca.<\/p>\n","protected":false},"excerpt":{"rendered":"We wtorek ruszy\u0142a kampania reklamowa Claritine SPE &#8211; leku o dzia\u0142aniu przeciwalergicznym, dost\u0119pnym bez recepty.","protected":false},"author":1,"featured_media":38057,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"csco_display_header_overlay":false,"csco_singular_sidebar":"","csco_page_header_type":"","csco_page_load_nextpost":"","csco_post_video_location":[],"csco_post_video_location_hash":"","csco_post_video_url":"","csco_post_video_bg_start_time":0,"csco_post_video_bg_end_time":0,"footnotes":""},"categories":[9642],"tags":[74],"class_list":{"0":"post-38056","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-atl","8":"tag-havas","9":"cs-entry","10":"cs-video-wrap"},"_links":{"self":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/38056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/comments?post=38056"}],"version-history":[{"count":0,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/posts\/38056\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media\/38057"}],"wp:attachment":[{"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/media?parent=38056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/categories?post=38056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mediarun.com\/pl\/wp-json\/wp\/v2\/tags?post=38056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}